Back to Search
MICHAEL ALTAWEEL, MD
MD
Ophthalmology Physician
NPI: 1700853876IndividualAccepts Medicare
Specialties, Licenses & Credentials
Ophthalmology PhysicianPrimary
Ophthalmology
Code: 207W00000X
39782(WI)
CMS Specialties
PrimaryOPHTHALMOLOGY
Education
OTHER
Class of 1990
Clinical Trials (1)
1
Linked Trials
0
Recruiting
1
With Results
Research & Publications (20)
Seven-Year Outcomes of Uveitic Macular Edema: The Multicenter Uveitis Steroid Treatment Trial and Follow-up Study Results.
PMID 32918964·Ophthalmology·2021
4-observational
Association Between Long-Lasting Intravitreous Fluocinolone Acetonide Implant vs Systemic Anti-inflammatory Therapy and Visual Acuity at 7 Years Among Patients With Intermediate, Posterior, or Panuveitis.
PMID 28477440·JAMA·2017
4-observational
Using a patient-centered approach to benefit-harm assessment in treatment decision-making: a case study in uveitis.
PMID 26798977·Pharmacoepidemiol Drug Saf·2016
4-observational
Outcome Preferences in Patients With Noninfectious Uveitis: Results of a Best-Worst Scaling Study.
PMID 26501236·Invest Ophthalmol Vis Sci·2015
4-observational
Optical coherence tomography evaluation in the Multicenter Uveitis Steroid Treatment (MUST) trial.
PMID 23163490·Ocul Immunol Inflamm·2012
4-observational
Hypotony in patients with uveitis: The Multicenter Uveitis Steroid Treatment (MUST) Trial.
PMID 22409563·Ocul Immunol Inflamm·2012
4-observational
Associations among visual acuity and vision- and health-related quality of life among patients in the multicenter uveitis steroid treatment trial.
PMID 22247489·Invest Ophthalmol Vis Sci·2012
4-observational
Identifying a clinically meaningful threshold for change in uveitic macular edema evaluated by optical coherence tomography.
PMID 21861971·Am J Ophthalmol·2011
4-observational
Randomized comparison of systemic anti-inflammatory therapy versus fluocinolone acetonide implant for intermediate, posterior, and panuveitis: the multicenter uveitis steroid treatment trial.
PMID 21840602·Ophthalmology·2011
4-observational
Validation of a photographic vitreous haze grading technique for clinical trials in uveitis.
PMID 21652026·Am J Ophthalmol·2011
4-observational
Ocular and systemic safety evaluation of calcium formate as a dietary supplement.
PMID 19456257·J Ocul Pharmacol Ther·2009
3-trial
Radial optic neurotomy using nasal and temporal approach incisions: histopathologic study in human cadaver eyes.
PMID 17998516·Arch Ophthalmol·2007
8-other
Macular hole: improved understanding of pathogenesis, staging, and management based on optical coherence tomography.
PMID 14566624·Semin Ophthalmol·2003
6-review
Pegaptanib sodium for macular edema secondary to central retinal vein occlusion.
PMID 19365011·Arch Ophthalmol·2009
3-trial
Diabetic macular edema: what is focal and what is diffuse?
PMID 18774122·Am J Ophthalmol·2008
6-review
Changes in retinal neovascularization after pegaptanib (Macugen) therapy in diabetic individuals.
PMID 16343627·Ophthalmology·2006
8-other
A phase II randomized double-masked trial of pegaptanib, an anti-vascular endothelial growth factor aptamer, for diabetic macular edema.
PMID 16154196·Ophthalmology·2005
3-trial
Intravitreal triamcinolone for the treatment of macular edema associated with central retinal vein occlusion.
PMID 15302652·Arch Ophthalmol·2004
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2880 UNIVERSITY AVE
MADISON, WI 53705 - Phone
- (608) 263-9339
Quick Facts
- NPI
- 1700853876
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 36
- Clinical Trials
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile